It can happen so easily. You’re excited about an experiment, so you sneak an early peek at the data to see if the P value — a measure of statistical significance — has dipped below the threshold of ...
Young men who play team sports in Ireland are four times more likely to participate in gambling on a regular basis than those who did not play any team game between the ages of 17 and 20, new research ...
There has been a “significant” increase in the number of incidents involving difficult and unruly passengers on flights operated by Irish air carriers, The Irish Aviation Authority (IAA) has said. In ...
Basel, June 2, 2025 – Novartis today announced topline results from a pre-specified interim analysis of the Phase III PSMAddition trial. The trial met its primary endpoint with a statistically ...
Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus chemo alone in resectable NSCLC. Among adult patients with resectable ...
MIAMI, May 30, 2025--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced topline results from the Phase III clinical trial, HARMONi, the first ...
Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1.3% to 1.6% across doses The investigational once-daily oral pill reduced weight ...
NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Newly released results from a randomized controlled trial (RCT), funded in part by Accelerate, found that middle school students who received virtual ...
CHICAGO and FORT WORTH, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing ...
Baxdrostat 2mg lowered systolic blood pressure by 15.7 mmHg (9.8 mmHg placebo-adjusted) from baseline, and was generally well tolerated with no unanticipated safety findings Full results presented at ...
Patients lived significantly longer without high-risk disease recurrence or progression after one year of IMFINZI treatment plus Bacillus Calmette-Guérin (BCG) induction and maintenance therapy vs.